Who’s Hired? Pfenex’ Lucy Joins Lykan Bioscience
As Samsung Biologics Names New President And CEO
Pfenex founder and chief business officer Patrick Lucy has left the company to join Lykan Bioscience. Meanwhile, Samsung Biologics has announced the appointment of a new president and CEO, as the Australian generics and biosimilars association appoints a new chair.
You may also be interested in...
Despite a slight increase in revenue, South Africa’s Adcock continues to struggle as it reports a continued drop in gross profit. The company expects the economy to remained constrained due to COVID-19, but is eagerly anticipating recovery with the government’s vaccine roll-out.
Prescribing reforms introduced from the start of February in Australia will see doctors prioritize active ingredients over brand names, following negotiations with government by the country’s GBMA off-patent industry association.
Australian off-patent industry association the GBMA says it has begun negotiations on a new strategic agreement with the government that will offer “long-term certainty” for the sector. Meanwhile, the industry body has praised the latest “pandemic budget” measures to address the impact of COVID-19.